HansonJATrentJCYangDCooperK. Small-intestinal rhabdoid gastrointestinal stromal tumor (GIST): mutation analysis and clinical implications of a rare morphological variant. Int J Surg Pathol. 2011;19:653-657.
2.
PauwelsPDebiec-RychterMStulMDe WeverIVan OosteromATSciotR. Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall. Histopathology. 2005;47:41-47.
3.
AntonescuCRRomeoSZhangL. Dedifferentiation in gastrointestinal stromal tumor to an anaplastic kit-negative phenotype: a diagnostic pitfall: morphologic and molecular characterization of 8 cases occurring either de novo or after imatinib therapy. Am J Surg Pathol. 2013;37:385-392.
4.
SjölundKAnderssonANilssonENilssonOAhlmanHNilssonB. Downsizing treatment with tyrosine kinase inhibitors in patients with advanced gastrointestinal stromal tumors improved resectability. World J Surg. 2010;34:2090-2097.
5.
LasotaJMiettinenM. Clinical significance of oncogenic KIT or PDGFRA mutations in gastrointestinal stromal tumours. Histopathology. 2008;53:245-266.
